Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Pier GB. Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa. US Patent 4,578,458 dated Mar 25 1986
Pier GB, et al. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. J. Infect. Dis. 147: 494-503, 1983. PubMed: 6220094
